CELGENE
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.
Lobbying Activity
Meeting with Jyrki Katainen (Vice-President)
30 Nov 2017 · Investment, innovation and IP protection
Meeting with Vytenis Andriukaitis (Commissioner) and
29 Nov 2017 · Pharmaceutical incentives, antimicrobial resistance
Meeting with Grzegorz Radziejewski (Cabinet of Vice-President Jyrki Katainen) and Biogen Inc.
27 Nov 2015 · Biopharmaceutical industry's contribution to jobs and growth
Meeting with Kaius Kristian Hedberg (Cabinet of Commissioner Elżbieta Bieńkowska), Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)
27 Apr 2015 · Biopharmaceutical industry
Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)
4 Feb 2015 · Access to innovative medicine
Meeting with Aura Salla (Cabinet of Vice-President Jyrki Katainen)
4 Feb 2015 · Janssen EMEA